Epidemiological synergy: Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases

Sexually Transmitted Diseases

Volumn 19, Issue 2, 1992, Pages 61-77

  Wasserhelt, Judith N ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE TRANSMISSION; GENITAL ULCER; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POLICY; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; COMORBIDITY; EPIDEMIOLOGIC METHODS; FEMALE; HUMAN; MALE; SEXUALLY TRANSMITTED DISEASES;

EID: 0027058409     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/00007435-199203000-00001     Document Type: Article

References (206)

1. Piot P. Laga M. Ryder R. et al. The global epidemiology of HIV infection: continuity, heterogeneity, and change. J Acq Imm DefSyn 1990:3:403-412.
2. Piot P. Plummer FA. Mhalu FS. et al. AIDS: an international perspective. Science 1988: 239:573-579.
3. Quinn TC. Mann JN. Curran JW, et al. AIDS in Africa: an epide miologic paradigm. Science 1986:234:955-963.
4. Bonneux L. Van der Stuyfi P. Taelman H. et al. Risk factors for infection with human immunodeficiency virus among European expatriates in Africa. Br Med J 1988: 297:581-584.
5. Bulterys M. Chao A. Saah A. et al. Risk factors for HIV-1 seropositivity among rural and urban pregnant women in Rwanda. Sixth International AIDS Conference, 1990. San Francisco. CA. Abstract number Th.C.576.
6. Cameron DW. D’Costa U. Ndinya-Achola JO. et al. Incidence and risk factors for female to male transmission of HIV. Fourth International AIDS Conference. 1988. Stockholm. Sweden. Abstract number 4061.
7. Cameron DW, Lourdes JD. Gregory MM. et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989:2:403-407.
8. Cannon RO, Quinn T. Rompalo A. et al. Syphilis is strongly associated with HIV infection in Baltimore STD Ginic patients independent of risk group. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number Th.A.0.18.
9. Cannon RO. Hook EW, Nahmias AJ. et al. Association of herpes simplex virus type 2 with HIV infection in heterosexual patients attending sexually transmitted disease clinics. Fourth International AIDS Conference. 1988, Stockholm. Sweden. Abstract number 4558.
10. Carael M. Van de Perre PH. Lepage PH. et al. Human immunodeficiency virus transmission among heterosexual couples in Central Afπca. AIDS 1988: 2:201-205.
11. Carswell JW. HIV infection in healthy persons in Uganda. AIDS 1987: 1:223-227.
12. Castro KG. Lieb S. Calisher C. et al. AIDS and HIV infection. Belle Glade. Florida. Third International AIDS Conference. 1987. Washington. DC. Abstract number W.2.3.
13. Chiphangwi J. Dallabetta G. Saah A. et al. Risk factors for HIV-1 infection in pregnant women in Malawi. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number Th.C.98.
14. Chirgwin K. Dillon S. DeHovitz J. et al. Genital ulcers (GU) and HIV infection in an urban sexually transmitted disease (STD) clinic. Fifth International AIDS Conference. 1989. Montreal. Canada Abstract number M.B.P.57.
15. Chmiel JS. Detels R. Kaslow RA. et al. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the multicenter AIDS cohort studv. Am J Epidemiol 1987: 128:568-575. ló. Collier A. Murphy V. Quinn i. et al. Seroepidemiology of HIV infection in adults with syphilis. Fourth International AIDS Conference. 1988. Stockholm. Sweden. Abstract number 4549.
16. Collier A. Murphy V. Quinn I. et al. Seroepidemiology of HIV infection in adults with syphilis. Fourth International AIDS Conference. 1988. Stockholm. Sweden. Abstract number 4549.
17. Darrow WW. Cohen JB. French J. et al. Multicenter study of HIV antibody in U.S. prostitutes. Third International AIDS Conference. 1987. Washington. DC. Abstract number W.2.1.
18. Darrow WW. Echenberg DF. Jaffe HW. et al. Risk factors for human immunodeficiency virus (HIV) infections in homosexual men. Am J Public Health 1987: 77:479-483.
19. de Vincenzi I. Ancelle-Park R. Heterosexual transmission of HIV. a European study. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number Th.A.0.20.
20. Duerr A. Buherys M. Dushimimana A. et al. HIV-1 seropositivity and sexual history among Rwandan women. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number Th.C.575.
21. Elifson K. Soles J. Sweet H. et al. Risk factors for HIV infection among male prostitutes in Atlanta. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number W.A.P.3S.
22. European Study Group. Risk factors for male to female transmis sion of HIV Br Med J 1989:298:411-415.
23. Fischl MA. Dickinson GM. Flanagan S. et al. Human immunode ficiency virus (HIV) among female prostitutes in South Florida. Third international AIDS Conference. 1987. Washington. EX. Abstract number W.2.2.
24. Fisch IMA. Fayne T. Flanagan S. et al Seroprev alence and risks of HIV infections in spouses of persons infected with HIV. Fourth International AIDS Conference. 1988. Stockholm. Sweden. Abstract number 4060.
25. Freund CO. Altman R. Shahied SI. et al. Prevalence of human immunodeficiency virus (HIV) infection in the sexually transmitted disease (STD) clinics of New Jersey. Fourth International AIDS Conference. 1988. Stockholm. Sweden. Abstract number 6093.
26. Greenblatt RM. Lukehart SA. Plummer FA. et al. Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS 1988: 2:47-50.
27. Haley CE. Anderson P. Freeman A. et al. Relationship of STD history to HIV seropositivity in a cohort of homosexual men in Dallas. Texas. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number W.a.P.39.
28. Hamson WO. Zajdowicz T. Hendrick B. et al. A comparison of history of sexually transmitted disease (STD) in HIV-positive vs HIV-negative naval personnel. Fourth International AIDS Conference. 1988. Stockholm. Sweden. Abstract number 4636.
29. Hayes CG. Manaloto CR. Basaca-Sevilla V. et al. Epidemiology of HIV infection among prostitutes in the Philippines. J Acq lmm Def Syn 1990:3:913-920.
30. Heilman N. Naubuga P. Baingana B. et al. HIV infection among patients in a Uganda STD clinic. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number Th.C.577.
31. Hermans P. Lee FK. Poncin M. et al. Possible co-factors of hu man immunodeficiency virus (HIV) infection among central African patients. Third International AIDS Conference. 1987. Washington. DC. Abstract number THP.61.
32. Hira SK. Kamanga J. Macuacua R. et al. Genital ulcers and male circumcision as risk factors for acquiring HIV-1 in Zambia. J Infect Dis 1990:161:584-585.
33. Holmberg SD. Stewart JA. Gerber AR. et al. Prior herpes simplex virus tvpe 2 infection as a risk factor for HIV infection. JAMA 1988: 259:1048-1050.
34. Hudson CP. Hennis AJ. Kaaha P. Risk factors for the spread of AIDS in rural Africa: evidence from a comparative seroepidemiolocal survey of AIDS, hepatitis B and syphilis in southwestern Uganda. AIDS 1988:2:255-260.
35. Hunter D. Maggwa A. Mali J. et al. Risk factors for HIV infection among women in a Iow-risk population in Nairobi. Kenya. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number Th.C.573.
36. Jaffe HW. Choi K. Thomas PA. et al. National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: 1. Epidemiologic results. Ann Intern Med 1983:99:145-151.
37. Katzenstein DA. Latif A. Bassett MT. et al. Risks for heterosexual transmission of HIV in Zimbabwe. Third International AIDS Conference. 1987. Washington. EX. Abstract number M.8.3.
38. Keel PM. Lee FK. Van Griansvan GJP. et al. Little evidence for genital ulcerative infections as a risk factor for HIV-l acquisition among homosexual men. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number Th.C.561.
39. Kingsley LA. Armstrong J. Rahman A. et al. No association be tween herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acq lmm Def Syn 1990: 3:773-779.
40. Kingsley LA. Kaslow R. Rinaldo CR. et al. Risk factors for sero conversion to human immunodeficiency virus among male homosexuals. Lancet 1987; 1:345-349.
41. Kiviat N. Rompalo A. Bowden R. et al. Anal human papilloma virus infection among human immunodeficiency virus-seropositive and-seronegative men. J Infect Dis 1990:162:358-361.
42. Kreiss JK. Koech D. Plummer FA. et al. AIDS virus infection in Nairobi prostitutes. N Engl J Med 1986: 314:414-418.
43. Laga M. Nzila N. Manoka AT. et al. High prevalence and inci dence of HIV and other sexually transmitted diseases (STD) among 801 Kinshasa prostitutes. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number Th.A.O.21.
44. Laga M. Nzila N. Manoka AT. et al. Non ulcerative sexually transmitted diseases (STD) as risk factors for HIV infection. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number Th.C.97.
45. Latif AS. Katzenstein DA. Bassett MT. Genital ulcers and trans mission of HIV among couples in Zimbabwe. AIDS 1989: 3:519-523.
46. Leonard G. Mounier M. Verdier M. et al. Seroepidemiological study of sexually transmitted pathogenic agents (HIV-1. HIV-2. T. pallidum. C. trachomatis) in Ivory Coast. Fourth International AIDS Conference. 1988. Stockholm. Sweden. Abstract number 5014.
47. Moss GB. D'Costa U. Ndinya-Achola JO. et al. Cervical ectopy and lack of male circumcision as risk factors for heterosexual transmission of HIV in stable sexual partnerships in Kenya. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number Th.C.570.
48. Moss GB. D’Costa LJ. Plummer FA. et al. HIV transmission in stable sexual partnerships in Kenya. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number T.A.P.88.
49. Nzila N. Ryder R. Colebunders R. et al. Married couples in Zaire with discordant HIV serology. Fourth International AIDS Conference. 1988. Stockholm. Sweden. Abstract number 4059.
50. Nzila. Kivuvu M. Manoka AT. et al. HIV risk factors in steady male partners of Kinshasa prostitutes. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number Th.C.579.
51. Nzila N. De Cock KM. Forthal DN. et al. The prevalence of infection with human immunodeficiency virus over a 10-year period in rural Zaire. N Engl J Med 1988:318:276-279.
52. O’Farrell N. Windsor I. Becker P. Risk factors for HIV-1 amongst STD clinic attenders in Durban. South Africa. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number F.C.604.
53. Ombette JJ. Ndinya-Achola JO. Maitha G. et al. Prevalence of HIV among men and women with H. ducreyi and Neisseria gonorrhoeae infection in Nairobi. Kenya. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number Th.C.572.
54. Pioi P. Plummer FA. Rev MA. et al. Retrospective seroepidemiology of AIDS virus infection in Nairobi populations. J Infect Dis 1987; 155:1108-1112.
55. Pioi P. Quinn TC. Taelman H. et al. Acquired immunodeficiency sYndrome in a heterosexual population in Zaire. Lancet 1984:2:65-69.
56. Piot P. Van Dyck E Ryder RW. et al. Serum antibody to Haemo philus ducreyi as a risk factor for HIV in Africa, but not in Europe. Fifth International AIDS Conference. 1989, Montreal. Canada. Abstract number M.A.0.32.
57. Plourde P. Plummer FA. Pepin J. et al. Incidence of HIV-1 sero conversion in women with genital ulcers. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number Th.C.571.
58. Plummer FA. Simonsen JN. Cameron DW. et al. Co-factors in male-female transmission of HIV. J Infect Dis 1991: 163:233-239.
59. Plummer FA. Pepin J, Maitha G. et al. HIV-1 infection in sex ually exposed women: risk factors for prevalent and incident infections. Fifth International AIDS Conference. 1989, Montreal. Canada. Abstract number T.A.P.87.
60. Quinn TC. Glasser D. Cannon RO. et al. Human immunodefi ciency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med 1988: 318:197-204.
61. Rogers MF. Morens DM. Stewart JA. et al. National case-control study of kaposi's sarcoma and pneumocystis carinii pneumonia in homosexual men: II. laboratory results. Ann Intern Med 1983:99:151-158.
62. Ryder R. Hassig S. Ndilu M. et al. Extramarital/prostitute sex and genital ulcer disease (GUD) are important HIV risk factor in 7068 male Kinshasa factory workers and their 4548 wives. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number M.A.0.35.
63. Safrin S. Dattel BJ. Hauer L. et al. Seroprevalence and epidemio logic correlates of human immunodeficiency virus infection in women with acute pelvic inflammatory disease. Obstet Gynecol 1990: 75:666-670.
64. Schachter MT. Boyko WJ. Weaver MS. et al. Progression to AIDS, predictions of AIDS, and seroconversion in a cohort of homosexual men: results of a four year prospective study. Third International AIDS Conference. 1987, Washington. DC. Abstract number M.3.3.
65. Shandera WX. The development of acquired immunodeficiency syndrome (AIDS) among two cohorts of sexually transmitted (STD) patients with different venereal disease histories. Fifth International AIDS Conference. 1989. Montreal, Canada. Abstract number W.A.P.45.
66. Simonsen JN. Cameron DW. Gakinya MN. et al. Human immu nodeficiency virus infection among men with sexually transmitted diseases. N Engl J Med 1988: 319:274-278.
67. Simonsen JN. Plummer FA, Ngugi EN. HIV infection among lower socioeconomic strata prostitutes in Nairobi. AIDS 1990: 4:139-144.
68. Stamm WE. Handsfield HH. Rompalo AM. et al. The associa tion between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988:260:1429-1433.
69. Stevens C. Taylor P. Holford T. et al. Co-factors and cohort ef fects in progression to AIDS among HIV-1 infected homosexual men. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number M.A.P.93.
70. Telzak EE. Chiasson MA. Stonebumer RL. et al. A prospective cohort study of HIV-1 seroconversion in patients with genital ulcer disease in New York City. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number M.A.O.34.
71. Telzak EE. Chiasson MA, Stonebumer R, et al. HI V seroconver sion in patients with genital ulcer disease in New York City: a prospective study. Sixth International AIDS Conference. 1990. San Francisco, CA. Abstract number 3194.
72. Van de Perre P. Carael M. Nzaramba D. et al. Risk factors for HIV seropositivity in selected urban-based Rwandese adults. AIDS 1987; 1:207-211.
73. Van de Perre P. Clumeck N. Steens M. et al. Seroepidcmiological study on sexually transmitted diseases and hepatitis B in African promiscuous heterosexuals in relation to HTLV-III infection. Eur J Epidemiol 1987:3:14-18.
74. Van de Perre P. Le Polain B. Carael M. et al. HIV Antibodies in a remote rural area in Rwanda. Central Africa: an analysis of potential risk factors for HIV seropositivity. AIDS 1987; 1:213-215.
75. Van de Perre P. Rouvroy D. Lepage P. et al. Acquired immunode ficiency syndrome in Rwanda. Lancet 1984: 2:62-65.
76. VanRaden M. Kaslow R. Kingsley L, et al. The role of ulcerative genital diseases in promoting acquisition of HIV-1 by nomosexual men. Fifth International AIDS Conference, 1989. Montreal. Canada. Abstract number Th.A.0.17.
77. Whittington WL, Jacobs B. Lewis J. et al. HIV-1 in patients with genital lesions attending a North American STD clinic: assessment of risk factors. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number T.A.P.l 18.
78. Wiznia A. Kashkin J. Caspe W. et al. HIV seroprevalence in patients with syphilis. Fourth International AIDS Conference, 1988. Stockholm. Sweden. Abstract number 4548.
79. Holmberg SD. Gerber AR. Stewart JA. et al. Herpes viruses as cofactors in AIDS. Lancet 1988:2:746-747.
80. Webster A. Lee CA, Cook DG. et al. Cytomegalovirus infection and progression towards AIDS in hemophiliacs with human immunodeficiency virus infection. Lancet 1989:2:63-65.
81. Kaslow RA. VanRaden M. DeLoria M. et al. Do clinical herpes simplex virus(HSV)and varicella-zoster(VSV) infections accelerate HIV-l-induced immunodeficiency? Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number Th.A.P.100.
82. Berger JR. McCarthy M. Resnick L. et al. History of syphilis as a cofactor for the expression of HIV infection. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number M.A.P.90.
83. Weber JN. McCreaner A. Berrie E.et al. Factors affecting seropos itivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Genitourin Med 1986:62:177-180.
84. Cameron DW. Plummer FA, D’Costa U. et al. Prediction of HIV infection by treatment failure for chancroid, a genital ulcer disease. Fourth International AIDS Conference. 1988. Stockholm, Sweden. Abstract number 7637.
85. MacDonald KS. Cameron W, D’Costa LJ, et al. Evaluation of fieroxacin (RO 23-6240) as single-oral-dose therapy of cultureproven chancroid in Nairobi, Kenya. Antimicrob Agents Chemother 1989; 33:612-614.
86. Quale J, Teplitz E, Augenbraun M. Atypical presentation of chancroid in a patient infected with the human immunodeficiency virus. Am J Med 1990; 88(5):43N-44N.
87. Latif AS. Epidemiology and control of chancroid. Eighth International Society for Sexually Transmitted Disease Research, 1989. Copenhagen. Denmark. Abstract number 66.
88. Hook EW. Syphilis and HIV infection. J Infect Dis 1989: 160:530-534.
89. Rufli T. Syphilis and HIV infection. Dermatologies 1989; 179:113-117.
90. Kinloch-de Loes S. Saurat JH. AIDS meets syphilis: changing patterns of the syphiiitic infection and its treatment. Dermatologira 1988: 177:261-264.
91. Matlow AG. Rachlis AR. Syphilis serology in human immunode ficiency virus-infected patients with symptomatic neurosyphilis: case report and review. Rev Infect Dis 1990; 12:703-707.
92. Terry PM. Page ML. Golmeier D. Are serological tests of value in diagnosing and monitoring response to treatment of syphilis in patients infected with human immunodeficiency virus? Genitourin Med 1988: 64:219-222.
93. Tramont EC. Syphilis in the AIDS era. N Engl J Med 1987; 316:1600-1601.
94. Caumes E. Janier M. Janssen F, et al. Atypical secondary syphilis in HIV seropositive patients. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number W.B.P.49.
95. Radolf JD. Kaplan RP. Unusual manifestations of secondary syphilis and abnormal humoral immune response to Treponema pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol 1988: 18:423-428.
96. Cusiπi M. Zerboni R. Muratori S. et al. Atypical early syphilis in an HIV-infected homosexual male. Dermatologica 1988; 177:300-304.
97. Berger JR. Hensley G. Moskowitz L. et al. Syphilitic myelopathy with human immunodeficiency virus: a treatable cause of spinal cord disease. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number W.B.P.51.
98. Stoumbos VD. Klein ML. Syphilitic retinitis in a patient with acquired immunodeficiency syndrome-related complex. Am J Ophthalmol 1987: 103:103-104.
99. Caπer JB. Hamill RJ. Matoba AY. Bilateral syphilitic optic neuri tis in a patient with a positive test for HIV. Arch Ophthalmol 1987; 105:1485-1486.
100. Johns DR. Tierney M. Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987; 316:1569-1572.
101. Reid SE. Neurosypĥilis and stroke in a patient with antibodies to the human immunodeficiency virus. Am J Med 1989; 87:119-121.
102. Katz DA. Berger JR. Neurosyphilis in acquired immunodefi ciency syndrome. Arch Neurol 1989; 46:895-897.
103. Pialoux G. Jobin D. Robinet M. et al. Syphilitic retinitis and uveitis in AIDS. Fourth International AIDS Conference, 1988, Stockholm. Sweden. Abstract number 7633.
104. Armignacco O. Antonucci G. Croce GF, et al. Syphilis and HIV infection. Fourth International AIDS Conference, 1988, Stockholm. Sweden. Abstract number 7634.
105. Bari MM. Shuldin DJ. Abell E. Ulcerative syphilis in acquired immunodeficiency syndrome: a case of precocious tertiary syphilis in a patient infected with human immunodeficiency virus. J Am Acad Dermatol 1989; 21:1310-1312.
106. Dawson S. Evans BA. Lawrence AG. Short communication be nign tertiary syphilis and HIV infection. AIDS 1988; 2:315-316.
107. Centers for Disease Control. Recommendations for diagnosing and treating syphilis in HIV-infected patients. MMWR 1988; 37:600-608.
108. Hicks CB. Benson PM. Lupton GP. et al. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with kaposi sarcoma. Ann Intern Med 1987; 107:492-495.
109. Morgello S. Laufer H. Quaternary neurosyphilis in a Haitian man with human immunodeficiency virus infection. Hum Pathol 1989:20:808-811.
110. Malessa R. Bahro M. Brockmeyer N. et al. Neurosyphilis in HIV-infected patients: evidence of unreliable serologic responses. Fifth International AIDS Conference, 1989, Montreal, Canada. Abstract number W.B.P.50.
111. Feraru ER, Aronow HA. Lipton RB. Neurosyphilis in AIDS pa tients: initial CSF VDRL may be negative. Neurology 1990: 40:541-543.
112. Berry CD. Hooton TM. Collier AC, et al. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987; 316:1587-1589.
113. Richards BW, Hessburg TJ, Nussbaum JN, et al. Recurrent syphi litic uveitis. N Engl J Med 1989; 320:60-61.
114. Duncan WC. Failure of erythromycin to cure secondary syphilis in a patient infected with the human immunodeficiency virus. Arch Dermatol 1989; 125:82-84.
115. Hook EW. Treatment of syphilis: current recommendations, al ternatives. and continuing problems. Rev Infect Dis 1989; 1151511-S1517.
116. Beck-Sague CM, Alexander ER, Jaffe HW. Neurosyphilis apd HIV infection. N Engl J Med 1987; 317:1473.
117. Jordan KG. Neurosyphilis and HIV infection. N Engl J Med 1987;317:1473-1474.
118. Fiumara N. Human immunodeficiency virus infection and syphi lis. J Am Acad Dermatol 1989; 21:141-142.
119. Fernandez-Guerrero ML, Miranda C, Cenjor C, et al. The treat ment of neurosyphilis in patients with HIV infection. JAMA 1988: 259:1495-1496.
120. Tseng CK, Hughes MA, Sell S. Altered immunity to syphilis in HIV-1-infected rabbits. Immunology 1990; 31:234. Abstract.
121. Lukehaπ SA, Hook EW, Baker-Zander SA, et aì. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988; 109:855-862.
122. Schultz S, Araneta MR, Joseph S, et al. Neurosyphilis and HIV infection. N Engl J Med 1987; 317:1474. Letter.
123. Manoka AT, Laga M, Kivuvu M. et al. Syphilis among HIV and HIV prostitutes in Kinshasa: prevalence and serologic response to treatment. Sixth International AIDS Conference, 1990. San Francisco. CA. Abstract number S.B.27.
124. Haas JS. Bolan G, Larsen S. et al. Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis 1990; 162:862-866.
125. Quinnan GV, Masur H. Rook AH. et al. Herpesvirus infections in the acquired immune deficiency syndrome. JAMA 1984; 252:72-77.
126. Sooy CD. Mills J. Herpes virus infection presenting as giant her petic nasal ulcers in AIDS. Fourth International AIDS Conference, 1988, Stockholm, Sweden. Abstract number 7096.
127. Siegal FP, Lopez C, Hammer GS. et al. Severe acquired immuno deficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981; 305:1439-1444.
128. Maier JA, Bergman A, Ross MG. Acquired immunodeficiency syndrome manifested by chronic primary genital herpes. Am J Obstet Gynecol 1986; 155:756-758.
129. Corey L. Genital herpes. In: Holmes KK, ed. Sexually Transmit ted Diseases. New York: McGraw Hill, 1990:399.
130. Gold D, Corey L. Acyclovir prophylaxis for herpes simplex virus infection. Antimicrob Agents Chemother 1987; 31:361-367.
131. Thin RN. Management of genital herpes simplex infections. Am J Med 1988; 85:3-6.
132. Conant MA. Prophylactic and suppressive treatment with acy clovir and the management of herpes in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1988; 18:186-188.
133. Birch CJ, Tachedjian G, Doherty RR, et al. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome. J Infect Dis 1990; 162:731-734.
134. Chatis PA. Miller CH, Schrager LE, et al. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with the acquired immunodeficiency syndrome. N Engl J Med 1989; 320:297-300.
135. Norris SA, Kessler HA, Fife KH. Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS. J Infect Dis 1988: 157:209-10. Letter.
136. Schinazi RF. del Bene V. Scon RT. et al. Characterization of acyclovir-resistant and -sensitive herpes simplex viruses isolated from a patient with an acquired immune deficiency. J Antimicrob Chemother 1986: 18(Suppl):127-134.
137. Youle MM. Hawkins DA. Collins P. et al. Acyclovir-resistant herpes in AIDS patients treated with Foscarnet Lancet 1988; 2:341-342.
138. Causey DM. Rarick MU. Melancon H. Foscamet treatment of acyclovir-resistant herpes simplex proctitis in an AIDS patient. Fourth International AIDS Conference. 1988, Stockholm. Sweden. Abstract number 3589.
139. Erlich K. Mills J. Chatis P. et al. Acyclovir-resistant herpes sim plex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989: 320:293-296.
140. Safrin S. Assaykeen T. et al. Foscarnet therapy for acyclovir-resis tant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data. J Infect Dis 1990; 161:1078-1084.
141. Doherty R. Hayes K. Birch C, et al. Evolution of foscarnet and acyclovir resistant herpes simplex infection in response to therapy. Sixth International AIDS Conference. 1990). San Francisco. CA. Abstract number Th.B.446.
142. EngJund JA. Zimmerman M. Erice A. et al. Development of herpes simplex virus (HSV) resistance to acyclovir in HIV infected patients. Fourth International AIDS Conference. 1988. Stockholm. Sweden. Abstract number 7095.
143. Byrne MA. Taylor-Robinson D. Munday PE. et al. The common occurrence of human papillomavirus infection and intraepithelial neoplasia in women infected by HIV. AIDS 1989: 3:379-382.
144. Caubel P. Poulques H. Katlama C. Multifocal human papilloma virus infections of the genital tract in HIV seropositive women. N Y State J Med 1990: 90:162-163.
145. Milbum PB. Brandsma JL. Goldsman CI. et al. Disseminated warts and evolving squamous cell carcinoma in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol 1988: 19:401-405.
146. Rudlinger R. Grob R. Buchmann P. et al. Anogenital warts of the condyloma acuminatum tvpe in HIV-positive patients. Dermatologica 1988: 176:277-28*8.
147. Palefsky J. Gonzales J. Greenblatt RM. et al. Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease. JAMA 1990: 263:2911-2916.
148. Feingold AR. Vermund SH. Burk RD. et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acq Imm Def Syn 1990:3:896-903.
149. Thomas G. Geraci A. Lavigne J. et al. Recurrent anogenital warts and HIV status. Sixth International AIDS Conference, 1990. San Francisco. CA. Abstract number Th.B.362.
150. McMillan A. Bishop PE. Clinical course of anogenital warts in men infected with human immunodeficiency virus. Genitourin Med 1989:65:225-228.
151. Bishop PE. McMillan A. Fletcher S. Immunological study of condylomata acuminata in men infected with the human immunodeficiency virus. Int J STD AIDS 1990: 1:28-31.
152. Bradbeer C. Is infection with HIV a risk factor for cervical intra epithelial neoplasia? Lancet 1987; 2:1277-1278.
153. Bradbeer CS. Heyderman E. The risk of progression of cervical dysplasia in women with HIV. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number M.B.P.58.
154. Henry MJ. Stanley MW. Cruikshank S. et al. Association of hu man immunodeficiency virus-induced immunosuppression with human papillomavirus infection and cervical intraepithelial neoplasia. Am J Obstet Gynecol 1989: 160:352-353.
155. Hiller KF. Lutz R. Baur M. et al. High rates of cervical dysplasias. cervical intra-epithelial neoplasias (CIN) and human papilloma virus infection in HIV infected female patients. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number M.B.P.60.
156. Pomeroy L. Boylan P. Murphy J. et al. Cervical intraepithelial neoplasia in HIV seronegative drug abusers. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number S.B.518.
157. Schrager LK. Friedland GH. Maude D, et al. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acq Imm Def Syn 1989; 2:570-575.
158. Schafer A. Wolfgang F, Mielke M, et al. Increased frequency of cervical dysplasia/neoplasia in HIV-infected women is related to the extent of immunosuppression. Sixth International AIDS Conference, 1990, San Francisco. CA. Abstract number S.B.519.
159. Muggiasca ML. Conti E Ravasi L, et al. Human immunodefi ciency virus and human papillomavirus in the cervical intraepithelial neoplasia (CIN) in development of past intravenous drug abusers (PIVDA) women. Fifth International AIDS Conference. 1989. Montreal. Canada. Abstract number M.B.P.56.
160. Goedert JJ, Caussey D. Palefsky J. et al. Anal pap smears and human papillomaviruses (HPV) in a 7-year cohort study of homosexual men. Proceedings of the Annual Meeting of the American Society of Clinical Oncologists 1990:9:A6.
161. Frazer IH, Medley G, Crapper RM, et al. The association be tween anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet 1986:2:657-660.
162. LaVigne J. Thomas G. Geraci A. et al. Occurrence of malignancy in the setting of anogenital warts in the gay male population. Sixth International AIDS Conference, 1990. San Francisco. CA. Abstract number S.B.520.
163. Vermund SH. Kelley DF, Burk RD. et al. Risk of human papillo mavirus (HPV) and cervical squamous intraepithelial lesions (SIL) highest among women with advanced HIV disease. Sixth International AIDS Conference. 1990. San Francisco. CA. Abstract number S.B.517.
164. Crocchiolo P. Lizioli A. Goisis F. et al. Cervical dysplasia and HIV infection. Lancet 1988; 2:238-239.
165. Plummer FA, Simonsen JN. Chubb H. et al. Epidemiological evidence for the development of serovar-specific immunity after gonococcal infection. J Gin Invest 1989: 83:1472-1476.
166. Moyle G. Barton SE Rowe IF. et al. Gonococcal arthritis caused bv auxotvpe P in a man with HIV infection. Genitourin Med 1990:66:91-92.
167. Hoegsberg B. Abulatia O. Sedlis A. et al. Sexually transmitted diseases and human immunodeficiency virus among women with pelvic inflammatory disease. Am J Obstet Gynecol 1990; 163:1135-1139.
168. Alexander NJ. Sexual transmission of HIV: virus entry into male and female tract. Fertil Steril 1990: 54:1-18.
169. Bagasra O. Freud M.Condoluci D. et al. Presence of HIV-1 in the sperms of HIV-seropositive individuals by DNA-hybridization and immunogold methods. Fifth International AIDS Conference. 1989, Montreal. Canada. Abstract number M.C.P.86.
170. Borzy MS. Connell RS. Kiessling AA. Detection of human immu nodeficiency virus in cell-free seminal fluid. J Acq Imm Def Syn 1988; 1:419-424.
171. Krieger JN, Coombs R. Collier A. et al. HIV recovery from se men: minimal impact of clinical stage of infection and minimal effect of semen analysis parameters. Sixth International AIDS Conference, 1990, San Francisco, CA. Abstract number Th.C.102.
172. Krieger JN, Coombs AC, Collier SO, et al. Patterns of human immunodeficiency virus excretion in semen of seropositive men: a cross-sectional and longitudinal study. Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapeutics. Atlanta. Georgia. 1990. Abstract number 309.
173. Van de Perre P. De Clercq A, Cogniaux-Leclerc J. et al. Detection of HIV p17 antigen in lymphocytes but not epithelial cells from cervicovaginal secretions of women seropositive for HIV: implications for heterosexual transmission of the virus. Genitourin Med 1988:64:30-33.
174. Vogt MW. Witt DJ. Craven DE. et al. Isolation of HTLV-III/ LAV from cervical secretions of women at risk for AIDS. Lancet 1986: 1:525-527.
175. Vogt MW, Win DJ. Craven DE. et al. Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106:380-382.
176. Wofsy CB. Cohen JB. Hauer LB. et al. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the vims. Lancet 1986; 1:527-529.
177. Wolff H. Anderson DJ. HIV in sperma. Hautarzt 1989; 40:737
178. Donegan SP. de la Monte S. Sieger KA, et al. HIV-1 infection of the lower female genital tract. Sixth International AIDS Conference, 1990. San Francisco. CA. Abstract number F.C.750.
179. Pomerantz RJ. de la Monte M, Donegan SP. et al. Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med 1988: 108:321-327.
180. Edwards JN, Morris HB. Langerfaans’ cells and lymphocyte sub sets in the female genital tract. Br J Obstet Gynecol 1985; 92:974-982.
181. Meltzer MS. Skillman DR. Gomatos PJ, et al. Role of mononu clear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu Rev Immunol 1990; 8:169-194.
182. Wolff H. Andeison DJ. Immunohistologic characterization and quantitation of leukocyte subpopulations in human semen. Fertil Steril 1988:49:497-504.
183. Bishop PE. McMillan A. Gilmour HM. Immunological study of the rectal mucosa of men with and without human immunodeficiency virus infection. Gut 1987; 28:1619-1624.
184. Mayer KH. Zierler S. Feingold L, et al. Sexually transmined diseases and genital tract inflammation among U.S. heterosexuals. at increased risk for HIV infection. Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapeutics. Atlanta. Georgia. 1990. Abstract number 307.
185. Wolff H. Anderson DJ. Male genital tract inflammation associated with increased number of potential human immunodeficiency virus host cells in semen. Andrologia 1988:20:404-410.
186. Cunningham AL. Turner RR. Miller AC. et al. Evolution of recurrent herpes simplex lesions. J Clin Invest 1985; 75:226-233.
187. Lukebart SA. Baker-Zander SA, Lloyd RM. et al. Characterization of lymphocyte responsiveness in early experimental syphilis. J Immunol 1980: 124:461-467.
188. Kiviat NB. Paavonen JA. Wolner-Hanssen P, et al. Histopathology of endocervical infection caused by C. trachomatis. HSV. T. vaginalis, and N, gonorrhoeae. Human Pathol 1990; 21:831-837.
189. Miller CJ. Alexander NJ. Sutjipto S. et al. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J Virol 1989: 63:4277-4284.
190. Kreiss JK. Coombs R. Plummer FA. et al. Isolation of human immunodeficiencyvirus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989; 160:380-384.
191. Plummer FA, Wainberg MA, Plourde P, et al. Detection of hu man immunodeficiency virus type 1 (HIV-1) in genital ulcer exudate of HIV-1-infected men by culture and gene amplification. J Infect Dis 1990; 161:810-811.
192. Quinn TC, Piot P, McCorrnick JB, et al. Serologic and immuno logic studies in patients with AIDS in North America and Africa. JAMA 1987; 257:2617-2621.
193. Hirsch MS, Schooley RT, Ho DD, et al. Possible viral interaction in the acquired immunodeficiency syndrome (AIDS). Rev Infect Dis 1984; 6:726-731.
194. Laurence J. Molecular interactions among herpesviruses and hu man immunodeficiency viruses. J Infect Dis 1990; 162:338-346.
195. Margolis DM, Parrott C, Leonard J, et al. The role of DNA bind ing motifs in transactivation of the HIV long terminal repeat (LTR) by herpes simplex virus type I (HSV-1). Sixth International AIDS Conference, 1990, San Francisco, CA. Abstract number S.A.229.
196. Borkowski JA, Albin R, Schwartz J, et al. The Epstein Barr virus (EBV) BZLF 1 gene product activates the HIV-1 5LTR. Sixth International AIDS Conference, 1990, San Francisco, CA. Abstract number S.A.230.
197. McCormack MH, Azad RF, Rosen JI, et al. Cytomegalovirus (CMV) induces HIV transcriptional activity in human fibroblasts. Sixth International AIDS Conference, 1990, San Francisco, CA. Abstract number S.A.225.
198. Skolnik PR. Kosloff BR. Hirsch MS. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J Infect Dis 1988; 157:508-514.
199. Pepin J, Plummer FA, Branham RC, et al. The interaction of HIV infection and other sexually transmitted diseases: an opportunity for intervention. AIDS 1989; 3:3-9.
200. Piot P, Laga M. Genital ulcers, other sexually transmitted dis eases. and the sexual transmission of HIV. Br Med J 1989; 298:623-624.
201. Kreiss JK, Carael M, Meheus A, et al. Role of sexually transmit ted diseases in transmitting human immunodeficiency virus. Genitourin Med 1988; 64:1-2.
202. Piot P, Kreiss JK, Ndinya-Achola JO, et al. Editorial reviewhet erosexual transmission of HIV. AIDS 1987; 1:199-206.
203. Piot P. Carael M. Epidemiological and sociological aspects of HIV-infection in developing countries. Br Med Bull 1988; 44:68-88.
204. World Health Organization. Report of the Research Sub-Com mittee of the AIDS/STD Task Force. July, 1990.
205. World Health Organization. Consensus statement from consulta tion on sexually transmitted diseases as a risk factor for HIV transmission. J Acq Imm Def Syn 1989; 2:248-255.
206. World Health Organization. Consensus statement from the consulation on global strategies for coordination of AIDS and STD control programmes. Geneva: World Health Organization, 1990, WHO/INF/90.2.